Dive Into Dollar Tr...
Health Care: Drugs
Sinovac Biotech Ltd. (SVA: NASDAQ)
$3.23 -0.03 | -0.92%
05/17/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 91.24M | 104.29M | 101.59M | 74.95M |
| Receivables | 23.44M | 17.83M | 25.77M | 24.54M |
| Inventories | 10.53M | 8.11M | 14.86M | 9.60M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 126.28M | 132.04M | 147.29M | 118.31M |
| Property, Plant & Equipment, Gross | 101.13M | 91.65M | 74.88M | 30.09M |
| Accumulated Depreciation & Depletion | 21.05M | 16.02M | 10.84M | 7.79M |
| Property, Plant & Equipment, Net | 80.08M | 75.63M | 64.04M | 22.31M |
| Intangibles | 1.15M | 1.34M | 1.35M | 695.11K |
| Other Non-Current Assets | 801.74K | 6.49M | 1.17M | 2.64M |
| Total Non-Current Assets | 82.48M | 83.87M | 67.06M | 26.16M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 208.76M | 215.91M | 214.36M | 144.48M |
| Accounts Payable | 15.24M | 22.75M | 13.54M | 10.57M |
| Short Term Debt | 3.33M | 4.71M | 10.44M | 17.70M |
| Other Current Liabilities | 2.69M | 8.63M | 4.10M | 11.33M |
| Total Current Liabilities | 30.15M | 40.64M | 45.76M | 50.01M |
| Long Term Debt | 31.18M | 17.32M | 10.06M | 407.79K |
| Deferred Income Taxes | 4.07M | 2.28M | 2.46M | 2.65M |
| Other Non-Current Liabilities | 13.92M | 10.37M | 8.32M | 6.94M |
| Minority Interest | -3.90M | 445.00K | -4.09M | 10.45M |
| Total Non-Current Liabilities | 60.88M | 45.34M | 42.16M | 23.81M |
| Total Liabilities | 91.04M | 85.99M | 87.92M | 73.82M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 117.72M | 129.92M | 126.44M | 70.66M |
| Common Par | 55.09K | 54.77K | 54.31K | 42.58K |
| Additional Paid In Capital | 106.25M | 117.19M | 104.15M | 42.53M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -12.16M | 2.70M | 3.88M | 13.99M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 23.58M | 9.98M | 18.36M | 14.09M |
| Total Capitalization | 148.91M | 147.24M | 136.50M | 71.07M |
| Total Equity | 117.72M | 129.92M | 126.44M | 70.66M |
| Total Liabilities & Stock Equity | 208.76M | 215.91M | 214.36M | 144.48M |
| Total Common Shares Outstanding | 55.09M | 54.77M | 54.31M | 42.59M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 54.93M | 54.61M | 53.06M | 42.58M |
| Diluted Weighted Shares Outstanding | 54.93M | 54.61M | 53.06M | 42.98M |
| Number of Employees | 652 | 614 | 483 | 400 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with SVA
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- Contributor7 Earnings Stocks to Watch
- Contributor5 Stocks Under-$10 Setting ...
- Usermon1
- UserSUPRATRADE Top 10 U.S.-List...
- Usertradee Portfolio 1
- UserMtsuneishi Portfolio 1
- Userfrychef's finest
- UserTachyon1
Latest SVA Headlines from TheStreet
- 5 Stocks Poised for Breakouts 04.05.13 | 02:04 pm
- 5 Stocks Under $10 Triggering Breakouts 03.14.13 | 01:03 pm
- Sinovac Biotech Ltd. Stock Downgraded (SVA) 11.19.12 | 04:11 am
- Sinovac Biotech Ltd. Stock Upgraded (SVA) 10.16.12 | 05:10 am
- 4 Biotech Stocks Under $10 Soaring Higher 09.25.12 | 02:09 pm
- Sinovac Biotech's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.15.12 | 11:08 am
- Sinovac Biotech Ltd. Stock Downgraded (SVA) 05.17.12 | 05:05 am
- Sinovac Biotech Ltd. Stock Upgraded (SVA) 04.02.12 | 04:04 am
- Sinovac Biotech Ltd. Stock Downgraded (SVA) 11.16.11 | 05:11 am
- 7 Earnings Reports to Watch Next Week 11.11.11 | 09:11 am
Press Releases for SVA
- Sinovac EV71 Vaccine Phase III Top-Line Results Presented At 13th Annual World Vaccine Congress & Expo - PR Newswire 04.18.13 | 07:04 am
- Sinovac Receives Commercial Approval In Mexico For Seasonal Flu Vaccine - PR Newswire 04.18.13 | 07:04 am
- Sinovac Schedules Conference Call And Webcast For Fourth Quarter And Full Year Unaudited Financial Results - PR Newswire 04.02.13 | 06:04 am
- Sinovac Reports Preliminary Top-Line Results From Phase III Clinical Trial For EV71 Vaccine Candidate Against Hand, Foot And Mouth Disease - PR Newswire 03.14.13 | 06:03 am
- Sinovac To Host Conference Call To Report Third Quarter 2012 Unaudited Financial Results - PR Newswire 10.29.12 | 08:10 am
- Sinovac Awarded Tenders In Beijing And Shanghai To Supply Inactivated Hepatitis A Vaccine Healive® Under Expanded Immunization Program - PR Newswire 09.25.12 | 08:09 am
- Sinovac Biotech Receives GMP Certification For Mumps Vaccine Production Facility - PR Newswire 09.18.12 | 08:09 am
- Sinovac Receives Beijing CDC Tender Award To Supply Seasonal Flu Vaccine Anflu(R) To Beijing Citizens - PR Newswire 09.10.12 | 08:09 am
- Sinovac Holds 2012 Annual General Meeting Of Shareholders - PR Newswire 08.23.12 | 08:08 am
- Sinovac To Host Conference Call To Report Second Quarter 2012 Unaudited Financial Results - PR Newswire 08.06.12 | 08:08 am
Partner Headlines for SVA
- 3 Vaccine Companies With Upcoming Catalysts - Seeking Alpha 09.09.12 | 08:09 am
- China Biotech Week in Review: Deals and Transactions, Trials and Approvals - Seeking Alpha 05.29.11 | 08:05 am
- China Biotech in Review: Thermo Fisher Scientific Displays Increased Commitment - Seeking Alpha 03.06.11 | 08:03 am
- 'Guru' Report Card: Grading the Picks of the Market's Biggest Names - Seeking Alpha 12.03.10 | 07:12 am
- Sinovac Biotech Upgraded at Brean Murray - Benzinga 11.11.10 | 09:11 am
- China Biotech Week in Review: Upping the Stakes - Seeking Alpha 08.22.10 | 08:08 am
- UPDATE 1-Sernova diabetes control device shows promise in pigs - Reuters 07.12.10 | 07:07 am
- Sinovac Wins Order for China’s National Immunization Program - Seeking Alpha 06.01.10 | 02:06 pm
- China Biotech Week in Review: IPO, Deals and Trials - Seeking Alpha 05.09.10 | 10:05 am
- Sinovac Hopes to Begin Mumps Vaccine Trial - Seeking Alpha 05.06.10 | 12:05 pm
